Market Tracker

01/29 5:04am ET

Albany Molecular Research Inc (NASDAQ:AMRI)

16.24
Data as of Jan 28
 +0.02 / +0.12%
Today’s Change
10.28
Today|||52-Week Range
23.95
-0.25%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close16.22
Today’s open16.35
Day’s range-- - --
Volume251,419
Average volume (3 months)648,624
Market cap$528.9M
Dividend yield--
Data as of 01/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2.86%
Earnings growth (next 5 years)+13.70%
Revenue growth (last year)+8.77%
P/E ratio162.4
Price/Sales1.26
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...-1.32-5.72%
LXRXLexicon Pharmaceutic...-0.04-4.05%
ARWRArrowhead Research C...-0.12-1.77%
EXELExelixis Inc+0.26+14.61%
Data as of 01/28/2015

Financials

Next reporting dateFebruary 9, 2015
EPS forecast (this quarter)$0.33
Annual revenue (last year)$246.6M
Annual profit (last year)$12.7M
Net profit margin5.14%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
SVP
Michael M. Nolan
Corporate headquarters
Albany, New York

Forecasts